Microbix Biosystems Inc. (TSX:MBX)

Market Cap	34.56M -38.9%
Revenue (ttm)	16.76M -27.2%
Net Income	-4.27M
EPS	-0.03
Shares Out	138.25M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	33,819
Open	0.2500
Previous Close	0.2500
Day's Range	0.2500 - 0.2500
52-Week Range	0.2100 - 0.4500
Beta	0.49
RSI	56.08
Earnings Date	May 14, 2026

About Microbix Biosystems

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of p...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 100
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: MBX